Latest News Archive
Please select Category, Year, and then Month to display items
07 January 2018
Photo Charl Devenish
Dr Anneke van der Spoel van Dijk is invested in contributing
to the global effort of stopping TB by 2035.
The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB).
She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB).
Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.
Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”
Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”
As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.
Kovsies’ Izelle Lategan named SA U/21 women’s hockey player of the year
2013-09-06
|
 |
Izelle Lategan
Photo: Supplied
06 September 2013 |
The South AfricanHockey Association named the Kovsie hockey striker, Izelle Lategan, as the U/21 women’s hockey player of the year.
Lategan, who matriculated from Paarl Gimnasium last year, already made her international debut for the SA U/16 squad against Argentina in 2010. She is currently a first-year BA Human Movement Science student at the university.
On provincial level she represented both the Free State women’s squad and the U/21 women’s side this year. She also captained the SA U/21 women’s hockey team and was called up to the women’s Protea side in 2013.
Her goal still remains to be part of the SA Hockey team for the 2016 Olympic Games.